HPV Awareness: take action to have one less worry!

Company news
2022-03-04

Five years ago, the International Papillomavirus Society (IPVS) announced that March 4th of each year would be designated as the International HPV Awareness Day (IHAD). It is an initiative which aims to increase public awareness of the virus to improve understanding of HPV and the importance of prevention, screening, diagnosis and treatment of papillomavirus-related diseases.

 

Human papillomavirus (HPV) is a common sexually transmitted infection virus that exists widely in nature and can be carried by human skin, digestive tract, and respiratory tract. In addition to the well-established etiology of cervical cancer, persistent HPV infection is the leading cause of cervical cancer in women. There is growing evidence that HPV also affects anal and genital tumors.

 

As a molecular diagnosis solution provider ever since 2010, we Bioperfectus has been dedicating in HPV DNA tests for decades. What we were we are; and we always will be.

 

For more information, please refer to Bioperfectus HPV rt-PCR Solution

 

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14